Jaws Sponsor LLC - Jun 4, 2021 Form 4 Insider Report for Cano Health, Inc. (CANO)

Role: 10%+ Owner
Signature: /s/ Michael Racich, Attorney-in-Fact for Barry Stuart Sternlicht, Authorized Signatory for Jaws Sponsor LLC
Stock symbol: CANO
Transactions as of: Jun 4, 2021
Transactions value $: $15,800,000
Form type: 4
Date filed: 6/7/2021, 06:15 PM
Next filing: Jul 23, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CANO	Class A common stock	Other		+17.2M			17.2M	Jun 4, 2021	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CANO	Class B ordinary shares	Other		-17.2M	-100%		0	Jun 4, 2021	Class A Ordinary Shares	17.2M		Direct	F1, F3
transaction	CANO	Warrants to purchase Class A common stock	Other	$15.8M	+10.5M		$1.50	10.5M	Jun 4, 2021	Class A Common Stock	10.5M	$11.50	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated November 11, 2020, by and among Jaws Acquisition Corp. ("Jaws"), Primary Care (ITC) Intermediate Holdings, LLC ("PCIH"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), Jaws domesticated as a Delaware corporation (the "Domestication") and changed its name to "Cano Health, Inc." ("Cano Health"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of Jaws, which were previously convertible into Class A ordinary shares of Jaws, were automatically converted into shares of Class A common stock of Cano Health, par value $0.0001 per share, on a one-for-one basis.
F2	Pursuant to the Private Placement Warrant Purchase Agreement, dated as of May 13, 2020, by and between Jaws and the reporting person, the reporting person purchased warrants to purchase Class A ordinary shares, which following the Domestication entitle the reporting person to purchase shares of Class A common stock of Cano Health (the "Private Placement Warrants") for a price of $1.50 per Private Placement Warrant. Upon consummation of the Business Combination, the Private Placement Warrants became exercisable, beginning 30 days after the closing of the Business Combination, for one share of Class A common stock at a price of $11.50 per share. The Private Placement Warrants expire on the fifth anniversary of the consummation of the Business Combination.
F3	Barry S. Sternlicht controls the reporting person, and as such has voting and investment discretion with respect to the securities held by the the reporting person and may be deemed to have beneficial ownership of the securities held directly by the reporting person.